Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apremilast in Chronic Cutaneous Sarcoidosis
NCT00794274Phase 3Completed
- Sponsor
- University of Cincinnati
- Start
- Nov 2008
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of apremilast in cutaneous sarcoidosis, sponsored by University of Cincinnati. Started Nov 2008; status: completed.
02
Drugs
apremilast
03
Conditions
cutaneous sarcoidosis
Beyond the preview
Go deeper on NCT00794274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00794274.